From Casetext: Smarter Legal Research

Pfizer Inc. v. Teva Pharms. USA, Inc.

United States Court of Appeals for the Federal Circuit
Nov 9, 2012
2012-1605 (Fed. Cir. Nov. 9, 2012)

Opinion

2012-1576 2012-1601 2012-1602 2012-1603 2012-1604 2012-1605 2012-1607

11-09-2012

PFIZER INC., WARNER-LAMBERT COMPANY LLC, AND CP. PHARMACEUTICALS INTERNATIONAL C.V., Plaintiffs-Appellees, AND NORTHWESTERN UNIVERSITY, Plaintiff-Appellee, v. TEVA PHARMACEUTICALS USA, INC. AND TEVA PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellants, AND LUPIN, LTD. AND LUPIN PHARMACEUTICALS, INC., Defendants-Appellants, AND ACTAVIS, INC. AND ACTAVIS ELIZABETH, LLC, Defendants-Appellants, AND COBALT LABORATORIES, INC. AND COBALT PHARMACEUTICALS, INC., Defendants-Appellants, AND SUN PHARMA GLOBAL, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., AND SUN PHARMACEUTICAL INDUSTRIES, INC., Defendants-Appellants, AND WOCKHARDT LIMITED AND WOCKHARDT USA, LLC, Defendants-Appellants, AND ALPHAPHARM PTY. LTD. AND MYLAN PHARMACEUTICALS, INC., Defendants-Appellants.


NOTE: This order is nonprecedential.

Appeals from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0307, Chief Judge Gregory M. Sleet.

ON MOTION


ORDER

Sun Pharma Global, Inc., Sun Pharmaceutical Industries, Ltd., and Sun Pharmaceutical Industries, Inc. move to withdraw Robert Breisblatt and Jeremy Daniel as counsel and substitute Barry P. Golob as principal counsel.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is granted.

FOR THE COURT

_________________

Jan Horbaly

Clerk
s26


Summaries of

Pfizer Inc. v. Teva Pharms. USA, Inc.

United States Court of Appeals for the Federal Circuit
Nov 9, 2012
2012-1605 (Fed. Cir. Nov. 9, 2012)
Case details for

Pfizer Inc. v. Teva Pharms. USA, Inc.

Case Details

Full title:PFIZER INC., WARNER-LAMBERT COMPANY LLC, AND CP. PHARMACEUTICALS…

Court:United States Court of Appeals for the Federal Circuit

Date published: Nov 9, 2012

Citations

2012-1605 (Fed. Cir. Nov. 9, 2012)